184 related articles for article (PubMed ID: 19181503)
1. Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.
Kim S; Choi JH; Lim HI; Lee SK; Kim WW; Kim JS; Kim JH; Choe JH; Yang JH; Nam SJ; Lee JE
Phytomedicine; 2009 Jun; 16(6-7):573-80. PubMed ID: 19181503
[TBL] [Abstract][Full Text] [Related]
2. Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells.
Kim S; Kim SH; Hur SM; Lee SK; Kim WW; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE; Yang JH
J Ethnopharmacol; 2009 Nov; 126(2):252-7. PubMed ID: 19715751
[TBL] [Abstract][Full Text] [Related]
3. Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
Oh SJ; Jung SP; Han J; Kim S; Kim JS; Nam SJ; Lee JE; Kim JH
Oncol Rep; 2013 Apr; 29(4):1343-8. PubMed ID: 23353996
[TBL] [Abstract][Full Text] [Related]
4. Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Lee SO; Jeong YJ; Im HG; Kim CH; Chang YC; Lee IS
Biochem Biophys Res Commun; 2007 Mar; 354(1):165-71. PubMed ID: 17214970
[TBL] [Abstract][Full Text] [Related]
5. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J; Kim S; Yang JH; Nam SJ; Lee JE
Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
[TBL] [Abstract][Full Text] [Related]
6. alpha-Mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells.
Lee YB; Ko KC; Shi MD; Liao YC; Chiang TA; Wu PF; Shih YX; Shih YW
J Food Sci; 2010; 75(1):H13-23. PubMed ID: 20492173
[TBL] [Abstract][Full Text] [Related]
7. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
[TBL] [Abstract][Full Text] [Related]
9. Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells.
Kim S; Han J; Kim JS; Kim JH; Choe JH; Yang JH; Nam SJ; Lee JE
Anticancer Res; 2011 Nov; 31(11):3767-73. PubMed ID: 22110198
[TBL] [Abstract][Full Text] [Related]
10. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
J Cell Biochem; 2012 Dec; 113(12):3653-62. PubMed ID: 22740037
[TBL] [Abstract][Full Text] [Related]
11. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms.
Cho HJ; Kang JH; Kwak JY; Lee TS; Lee IS; Park NG; Nakajima H; Magae J; Chang YC
Carcinogenesis; 2007 May; 28(5):1104-10. PubMed ID: 17114644
[TBL] [Abstract][Full Text] [Related]
12. 12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells.
Kim S; Lee HS; Lee SK; Kim SH; Hur SM; Kim JS; Kim JH; Choe JH; Shin I; Yang JH; Lee JE; Nam SJ
Phytomedicine; 2010 Dec; 17(14):1127-32. PubMed ID: 20554189
[TBL] [Abstract][Full Text] [Related]
13. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of nitric oxide-dependent inhibition of TPA-induced matrix metalloproteinase-9 (MMP-9) in MCF-7 cells.
Jespersen C; Doller A; Akool el-S; Bachmann M; Müller R; Gutwein P; Mühl H; Pfeilschifter J; Eberhardt W
J Cell Physiol; 2009 May; 219(2):276-87. PubMed ID: 19130490
[TBL] [Abstract][Full Text] [Related]
15. Glial cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling.
Chandrasekar N; Mohanam S; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Clin Cancer Res; 2003 Jun; 9(6):2342-9. PubMed ID: 12796404
[TBL] [Abstract][Full Text] [Related]
16. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.
Lee SO; Jeong YJ; Kim M; Kim CH; Lee IS
Biochem Biophys Res Commun; 2008 Feb; 366(4):1019-24. PubMed ID: 18088599
[TBL] [Abstract][Full Text] [Related]
17. Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells.
Kim S; Han J; Lee SK; Choi MY; Kim J; Lee J; Jung SP; Kim JS; Kim JH; Choe JH; Lee JE; Nam SJ
J Surg Res; 2012 Jul; 176(1):e21-9. PubMed ID: 22381172
[TBL] [Abstract][Full Text] [Related]
18. Luteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cells.
Park SH; Kim JH; Lee DH; Kang JW; Song HH; Oh SR; Yoon DY
Biochimie; 2013 Nov; 95(11):2082-90. PubMed ID: 23933110
[TBL] [Abstract][Full Text] [Related]
19. Radix clematidis extract inhibits TPA-induced MMP-9 expression by suppressing NF-κB activation in MCF-7 human breast cancer cells.
Noh EM; Lee YR; Hur H; Kim JS
Mol Med Rep; 2011; 4(5):879-83. PubMed ID: 21805048
[TBL] [Abstract][Full Text] [Related]
20. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
